Dossenheim, Germany

Bernhard Günther

USPTO Granted Patents = 29 

 

 

Average Co-Inventor Count = 3.6

ph-index = 13

Forward Citations = 511(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents

Title: Bernhard Günther: Innovating in Ophthalmic Solutions

Introduction: Bernhard Günther is a prominent inventor based in Dossenheim, Germany, known for his significant contributions to the field of biopharmaceuticals. With a remarkable portfolio of 24 patents, his work primarily revolves around novel compositions for medical applications, particularly in ophthalmology.

Latest Patents: One of Günther's latest patents focuses on "Compositions comprising mixtures of semifluorinated alkanes." This invention presents innovative compositions that utilize semifluorinated alkanes, aimed at treating keratoconjunctivitis sicca (dry eye) and meibomian gland dysfunction. These compositions hold promise for topical administration to the eye, and he has also developed kits comprising these formulations. Another notable patent is for "Stabilized antibody compositions," which improves the stability and shelf-life of antibodies using liquid vehicles made from semifluorinated alkanes. These compositions are poised for use in both topical administration and parenteral injections, showcasing Günther's pioneering spirit in enhancing therapeutic options.

Career Highlights: Bernhard Günther is currently associated with Novaliq GmbH, where he continues to play an integral role in advancing innovative medical solutions. His extensive research and development efforts have significantly impacted the field of ophthalmology, paving the way for new treatment modalities that incorporate his patented inventions.

Collaborations: Throughout his career, Günther has worked alongside talented professionals such as Bastian Theisinger and Sonja Theisinger. These collaborations have fostered an environment of creativity and innovation, driving forward the development of effective medical treatments using his groundbreaking ideas.

Conclusion: Bernhard Günther stands out as a key figure in the landscape of pharmaceutical innovation. His commitment to developing novel therapies for eye-related health issues underscores the importance of research and invention in improving patient outcomes. As he continues to innovate through his work at Novaliq GmbH, the impact of his contributions is certain to be felt in the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…